Literature DB >> 15896841

Establishment of a novel human B-CLL-like xenograft model in nude mouse.

Severine Loisel1, Karine Le Ster, Isabelle Quintin-Roue, Jacques-Olivier Pers, Anne Bordron, Pierre Youinou, Christian Berthou.   

Abstract

We have developed a novel murine model for B-CLL by engrafting human prolymphocytic leukemia (PLL) or B-CLL cell line cells (JVM-3 and MEC-2 cell lines, respectively) into nude mice. Not only treatment of the mice was a prerequisite for the success of the graft, but also for the first time, females appeared to accept the cells more easily than males. Surprisingly, tumoral murine models for B-CLL could be established with PLL cells but not with B-CLL cells. JVM-3 cells were efficiently transplanted into nude mice through subcutaneous or intravenous routes. Irradiated female mice appeared to be the optimal recipients for tumor growth. Such murine models for human B-CLL may help the development of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896841     DOI: 10.1016/j.leukres.2005.04.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.

Authors:  Alba Matas-Céspedes; Anna Vidal-Crespo; Vanina Rodriguez; Neus Villamor; Julio Delgado; Eva Giné; Heleia Roca-Ho; Pablo Menéndez; Elías Campo; Armando López-Guillermo; Dolors Colomer; Gaël Roué; Adrian Wiestner; Paul W H I Parren; Parul Doshi; Jeroen Lammerts van Bueren; Patricia Pérez-Galán
Journal:  Clin Cancer Res       Date:  2016-09-16       Impact factor: 12.531

2.  Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.

Authors:  Rajesh Kumar Gandhirajan; Peter Anton Staib; Katharina Minke; Iris Gehrke; Günther Plickert; Axel Schlösser; Esther Katharina Schmitt; Michael Hallek; Karl-Anton Kreuzer
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

3.  The Antineoplastic Effect of Nitric Oxide-Donating Acetylsalicylic Acid (NO-ASA) in Chronic Lymphocytic Leukemia (CLL) Cells is Highly Dependent on its Positional Isomerism.

Authors:  Iris Gehrke; Regina Razavi; Simon Jonas Poll-Wolbeck; Albrecht Berkessel; Michael Hallek; Karl-Anton Kreuzer
Journal:  Ther Adv Hematol       Date:  2011-10

Review 4.  Animal models of leukemia: any closer to the real thing?

Authors:  Guerry J Cook; Timothy S Pardee
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

5.  Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia.

Authors:  Séverine Loisel; Karine Le Ster; Michèle Meyer; Christian Berthou; Pierre Youinou; Jean-Pierre Kolb; Christian Billard
Journal:  J Hematol Oncol       Date:  2010-12-07       Impact factor: 17.388

6.  Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.

Authors:  Séverine Loisel; Pierre-Alain André; Josee Golay; Franz Buchegger; Jean Kadouche; Martine Cérutti; Luca Bologna; Marek Kosinski; David Viertl; Angelika Bischof Delaloye; Christian Berthou; Jean-Pierre Mach; Laurence Boumsell
Journal:  Mol Cancer       Date:  2011-04-19       Impact factor: 27.401

Review 7.  Understanding CLL biology through mouse models of human genetics.

Authors:  Elisa Ten Hacken; Catherine J Wu
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476

8.  Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.

Authors:  Erin Hertlein; Kyle A Beckwith; Gerard Lozanski; Timothy L Chen; William H Towns; Amy J Johnson; Amy Lehman; Amy S Ruppert; Brad Bolon; Leslie Andritsos; Arletta Lozanski; Laura Rassenti; Weiqiang Zhao; Tiina M Jarvinen; Leigha Senter; Carlo M Croce; David E Symer; Albert de la Chapelle; Nyla A Heerema; John C Byrd
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

9.  C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia.

Authors:  Lindsay K Ryland; Ushma A Doshi; Sriram S Shanmugavelandy; Todd E Fox; Cesar Aliaga; Kathleen Broeg; Kendall Thomas Baab; Megan Young; Osman Khan; Jeremy K Haakenson; Nancy Ruth Jarbadan; Jason Liao; Hong-Gang Wang; David J Feith; Thomas P Loughran; Xin Liu; Mark Kester
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

10.  The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.

Authors:  Eahsan Rasul; Daniel Salamon; Noemi Nagy; Benjamin Leveau; Ferenc Banati; Kalman Szenthe; Anita Koroknai; Janos Minarovits; George Klein; Eva Klein
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.